NIFTY 50

Sun Pharma confirms it received two queries from Sebi

Updated : January 23, 2019 12:37 PM IST

Sun Pharmaceuticals has confirmed that the Securities and Exchange Board of India (Sebi) has sent two queries to the company to which the firm has already responded.

The development comes after a whistleblower complaint against the company over corporate governance issues.

Sun Pharma had come under a cloud over allegations of related-party transactions with Aditya Medisales.

A Mint report, citing sources, on Wednesday said that market regulator was investigating the company for allegedly failing to make accurate disclosures, financial irregularities and governance lapses.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV